Clinical trials have shown their potential in the treatment of idiopathic pulmonary fibrosis (IPF, 2018), 32 Alzheimers disease (AD, 2023, 2024, 2025), 33,34,35 diabetic macular edema (DME, 2024), 35 etc
A landmark review by Pickart and Margolina in Biomolecules confirming GHK-Cus broad gene regulatory influence on tissue repair pathways supports its complementary role alongside metabolic interventions like NAD+ therapy
The avian coronavirus infectious bronchitis virus undergoes direct low-pH-dependent fusion activation during entry into host cells
Do not apply this at the same time as an acid serum or cream
Lets break it down in a way that actually helps you decide
We prescribe them clinically never speculatively